HDO Health

HDO Health is a health care startup founded in 2021 with a mission to develop innovative technologies to prevent deaths from uncontrolled bleeding. Their flagship product, the HDO Health Journiquet™, addresses the critical issue of uncontrolled bleeding at the torso-appendage junction, a leading cause of preventable fatalities. The company aims to make the Journiquet™ easy to choose, easy to use, and a timesaver to be a lifesaver. According to their slogan, the Journiquet™ is designed to provide effective and sustained arrest of traumatic junctional bleeding at the point of injury and during patient transport, catering to both experienced and novice users. This addresses the limitations of existing specialized tourniquets, including issues related to weight, size, and ease of use. Notably, the HDO Health Journiquet™ will be compatible with storage within Individual First Aid Kits (IFAKs), enhancing its practicality and accessibility. The startup recently received a $1.00K grant investment on 09 November 2023 from Founders First CDC, a notable milestone in their journey. It's important to note that the device is pending 510(k) clearance by the U.S. Food and Drug Administration (FDA) and is not currently available for sale within the United States. In conclusion, HDO Health is positioning itself as an innovative player in the medical device space, aiming to address critical unmet needs in bleeding control. With a clear mission and product focus, the company has garnered support from investors, setting the stage for potential growth and impact in the healthcare industry.